Zacks Research Comments on RLI’s Q1 Earnings (NYSE:RLI)

RLI Corp. (NYSE:RLIFree Report) – Research analysts at Zacks Research boosted their Q1 2027 earnings per share (EPS) estimates for shares of RLI in a research report issued on Tuesday, August 11th. Zacks Research analyst Team now forecasts that the insurance provider will earn $0.77 per share for the quarter, up from their prior forecast of $0.74. The consensus estimate for RLI’s current full-year earnings is $2.88 per share. Zacks Research also issued estimates for RLI’s FY2027 earnings at $2.72 EPS.

RLI (NYSE:RLIGet Free Report) last announced its quarterly earnings data on Wednesday, July 22nd. The insurance provider reported $0.83 EPS for the quarter, beating analysts’ consensus estimates of $0.72 by $0.11. The business had revenue of $575.57 million during the quarter, compared to the consensus estimate of $568.70 million. RLI had a return on equity of 17.61% and a net margin of 22.22%.The business’s revenue for the quarter was up 15.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.82 earnings per share.

Other analysts have also recently issued research reports about the company. Weiss Ratings upgraded RLI from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, July 29th. UBS Group set a $74.00 price objective on shares of RLI in a report on Tuesday, July 28th. Wells Fargo & Company cut shares of RLI from an “equal weight” rating to an “underweight” rating and set a $57.00 target price on the stock. in a research report on Wednesday, July 29th. Keefe, Bruyette & Woods restated an “outperform” rating and issued a $74.00 target price (up from $70.00) on shares of RLI in a report on Tuesday, July 28th. Finally, Wall Street Zen raised shares of RLI from a “sell” rating to a “hold” rating in a research report on Saturday, August 1st. One research analyst has rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $63.00.

Get Our Latest Analysis on RLI

RLI Trading Down 1.8%

NYSE RLI opened at $62.76 on Thursday. The business’s 50-day moving average price is $58.92 and its 200 day moving average price is $57.70. RLI has a twelve month low of $47.26 and a twelve month high of $69.19. The company has a market capitalization of $5.76 billion, a PE ratio of 13.18 and a beta of 0.38.

Insider Transactions at RLI

In other news, COO Jennifer L. Klobnak acquired 2,000 shares of the business’s stock in a transaction dated Tuesday, May 19th. The shares were bought at an average cost of $53.42 per share, for a total transaction of $106,840.00. Following the acquisition, the chief operating officer directly owned 102,318 shares in the company, valued at $5,465,827.56. This trade represents a 1.99% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Craig W. Kliethermes bought 5,000 shares of the company’s stock in a transaction that occurred on Thursday, May 21st. The shares were acquired at an average cost of $52.00 per share, with a total value of $260,000.00. Following the transaction, the chief executive officer owned 148,990 shares in the company, valued at approximately $7,747,480. This represents a 3.47% increase in their position. The SEC filing for this purchase provides additional information. Insiders have bought a total of 16,500 shares of company stock worth $858,955 over the last ninety days. 2.39% of the stock is owned by insiders.

Institutional Investors Weigh In On RLI

Large investors have recently made changes to their positions in the business. Royal Bank of Canada raised its stake in shares of RLI by 115.1% in the 1st quarter. Royal Bank of Canada now owns 56,386 shares of the insurance provider’s stock valued at $4,529,000 after acquiring an additional 30,170 shares during the period. Goldman Sachs Group Inc. boosted its position in RLI by 110.8% during the 1st quarter. Goldman Sachs Group Inc. now owns 185,504 shares of the insurance provider’s stock worth $14,902,000 after purchasing an additional 97,501 shares during the period. Empowered Funds LLC increased its holdings in RLI by 472.3% in the 1st quarter. Empowered Funds LLC now owns 29,177 shares of the insurance provider’s stock valued at $2,344,000 after purchasing an additional 24,079 shares in the last quarter. EverSource Wealth Advisors LLC increased its holdings in RLI by 46.2% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,559 shares of the insurance provider’s stock valued at $113,000 after purchasing an additional 493 shares in the last quarter. Finally, Amundi raised its position in RLI by 16,550.0% in the second quarter. Amundi now owns 23,976 shares of the insurance provider’s stock valued at $1,689,000 after purchasing an additional 23,832 shares during the period. Institutional investors and hedge funds own 77.89% of the company’s stock.

More RLI News

Here are the key news stories impacting RLI this week:

  • Positive Sentiment: Zacks raised its FY2026 EPS forecast to $2.84 from $2.70, close to the current consensus estimate of $2.85. It also increased its FY2027 forecast to $2.72 from $2.64 and FY2028 to $2.73 from $2.51, signaling improved expectations for RLI’s longer-term profitability. RLI earnings estimate revisions
  • Positive Sentiment: Several quarterly estimates were raised, including Q4 2026 EPS to $0.67 from $0.64, Q4 2027 to $0.70 from $0.62, Q1 2027 to $0.77 from $0.74, and Q2 2028 to $0.79 from $0.71. These upgrades support the view that underwriting and investment performance could remain resilient. RLI quarterly earnings estimate revisions
  • Neutral Sentiment: The most recent revisions do not represent a new company announcement or change in guidance; they are analyst-model updates. RLI’s latest reported quarter had already exceeded expectations, with EPS of $0.83 versus a $0.72 consensus and revenue up 15.2% year over year.
  • Negative Sentiment: Zacks lowered its Q3 2026 EPS forecast to $0.51 from $0.53 and Q2 2027 to $0.67 from $0.69. Those reductions point to some expected earnings pressure in upcoming periods and may be contributing to the weaker share performance.

RLI Company Profile

(Get Free Report)

RLI Corporation (NYSE:RLI) is a specialty property and casualty insurance company focused on underwriting niche risks for businesses and individuals. Headquartered in Peoria, Illinois, the company operates through a network of independent agents and brokers, offering customized coverage solutions. RLI’s approach emphasizes disciplined underwriting, targeted product development and strong customer service to maintain profitability and long-term growth.

Founded in 1965 as Replacement Lens, Inc, RLI initially provided insurance for contact lens manufacturers before shifting its focus to specialty insurance in the 1980s.

Further Reading

Earnings History and Estimates for RLI (NYSE:RLI)

Receive News & Ratings for RLI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RLI and related companies with MarketBeat.com's FREE daily email newsletter.